Emmes appoints Matt Bond as CFO
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
The companies will work with investigators to share the results with the scientific community
Subscribe To Our Newsletter & Stay Updated